Psychological stress; knowledge, attitude and practice and acceptance of antiviral therapy in pregnant women with hepatitis B in Zhejiang, China: a case comparison study.

Xiaoxiao Liu, Can Chen, Daixi Jiang, Danying Yan, Yuqing Zhou, Cheng Ding, Lei Lan, Chenyang Huang, Xiaobao Zhang, Lanjuan Li, Shigui Yang
Author Information
  1. Xiaoxiao Liu: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  2. Can Chen: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  3. Daixi Jiang: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  4. Danying Yan: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  5. Yuqing Zhou: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  6. Cheng Ding: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  7. Lei Lan: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  8. Chenyang Huang: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  9. Xiaobao Zhang: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  10. Lanjuan Li: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. ORCID
  11. Shigui Yang: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China yangshigui@zju.edu.cn. ORCID

Abstract

OBJECTIVES: To determine knowledge, attitude and practice (KAP) and antiviral therapy's acceptance during pregnancy of pregnant women with hepatitis B and influencing factors.
DESIGN: Case-comparison study.
SETTING: The study was conducted in Zhejiang province, China, from September 2019 to December 2020.
PARTICIPANTS: Pregnant and postpartum women with chronic hepatitis B.
PRIMARY AND SECONDARY OUTCOME MEASURES: The stress scores, self-assessed health score, KAP, antiviral therapy's acceptance rate during pregnancy and influencing factors were analysed. The Perceived Stress Scale-10 was used to assess stress. Logistic regression was used to analyse influencing factors on antiviral therapy.
RESULTS: The self-assessed health score of pregnant women without liver diseases (82.4±9.3) was significantly higher than that of pregnant women with chronic hepatitis B (75.5±9.5) and postpartum (75.1±14.1). Psychological stress of pregnant women with chronic hepatitis B.was significantly high with a 14.9±3.6 score, but there was no significant difference between hepatitis B postpartum and non-liver disease women (12.7±3.5 vs 12.9±3.5, p=0.75). The acceptance rate of pregnant women with hepatitis B for antiviral therapy was 84.2%, while that of postpartum women was even higher. Logistic regression analysis showed that patients with positive hepatitis B e antigen (HBeAg) (OR, 3.35; 95% CI, 1.21 to 9.26) and higher scores on hepatitis B-related knowledge (OR, 3.52, 95% CI, 2.18 to 5.69) were more likely to accept antiviral therapy during pregnancy.
CONCLUSIONS: Pregnant women with hepatitis B in Zhejiang have heavy psychological stress and a high antiviral therapy acceptance rate during pregnancy. Acceptance is related to HBeAg status and level of understanding of hepatitis B during pregnancy. It is necessary to provide education on hepatitis B to reduce psychological stress and increase acceptance of antiviral therapy during pregnancy.

Keywords

References

  1. BMC Psychiatry. 2020 Mar 20;20(1):130 [PMID: 32197589]
  2. PLoS One. 2017 Jun 2;12(6):e0178671 [PMID: 28575040]
  3. PLoS One. 2014 Aug 21;9(8):e105530 [PMID: 25144199]
  4. J Health Soc Behav. 1983 Dec;24(4):385-96 [PMID: 6668417]
  5. World J Gastroenterol. 2013 Dec 28;19(48):9377-82 [PMID: 24409065]
  6. J Viral Hepat. 2017 Jun;24(6):514-521 [PMID: 28039902]
  7. Clin Infect Dis. 2015 Jan 15;60(2):275-8 [PMID: 25313254]
  8. Hepatology. 2015 Sep;62(3):684-93 [PMID: 25973979]
  9. J Clin Transl Hepatol. 2019 Sep 28;7(3):197-212 [PMID: 31608211]
  10. J Hepatol. 2017 Aug;67(2):370-398 [PMID: 28427875]
  11. Bull World Health Organ. 2015 Jan 1;93(1):52-6 [PMID: 25558108]
  12. Liver Int. 2016 Nov;36(11):1595-1603 [PMID: 27206379]
  13. J Acquir Immune Defic Syndr. 2017 Sep 01;76(1):1-12 [PMID: 28291053]
  14. Appl Nurs Res. 2020 Dec;56:151347 [PMID: 33280787]
  15. J Hepatol. 2013 Jul;59(1):24-30 [PMID: 23485519]
  16. Sci Rep. 2017 Jun 23;7(1):4132 [PMID: 28646142]
  17. J Viral Hepat. 2019 Oct;26(10):1170-1177 [PMID: 31177596]
  18. Gastroenterol Hepatol. 2020 Dec;43(10):640-648 [PMID: 32948358]
  19. Value Health. 2017 Apr;20(4):662-669 [PMID: 28408009]
  20. Front Psychol. 2020 Apr 09;11:537 [PMID: 32328009]
  21. Qual Life Res. 2020 Jul;29(7):1775-1787 [PMID: 32112277]
  22. Zhonghua Gan Zang Bing Za Zhi. 2019 Dec 20;27(12):938-961 [PMID: 31941257]
  23. Singapore Med J. 2020 Jan;61(1):24-27 [PMID: 31388686]
  24. J Viral Hepat. 2012 Feb;19(2):e18-25 [PMID: 22239517]
  25. Hum Vaccin Immunother. 2016;12(1):70-6 [PMID: 26211570]
  26. N Engl J Med. 2016 Jun 16;374(24):2324-34 [PMID: 27305192]
  27. Hepatology. 2014 Aug;60(2):468-76 [PMID: 25187919]

MeSH Term

Antiviral Agents
Case-Control Studies
DNA, Viral
Female
Health Knowledge, Attitudes, Practice
Hepatitis B
Hepatitis B e Antigens
Hepatitis B virus
Hepatitis B, Chronic
Humans
Infectious Disease Transmission, Vertical
Pregnancy
Pregnancy Complications, Infectious
Pregnant Women
Stress, Psychological

Chemicals

Antiviral Agents
DNA, Viral
Hepatitis B e Antigens

Word Cloud

Created with Highcharts 10.0.0hepatitisBwomenantiviralacceptancepregnantstresspregnancytherapypostpartum5knowledgeinfluencingfactorsstudyZhejiangchronicscorerate3higher75psychologicalattitudepracticeKAPtherapy'sPregnantscoresself-assessedhealthusedLogisticregressionsignificantly1Psychologicalhigh9±312HBeAgOR95%CIOBJECTIVES:determineDESIGN:Case-comparisonSETTING:conductedprovinceChinaSeptember2019December2020PARTICIPANTS:PRIMARYANDSECONDARYOUTCOMEMEASURES:analysedPerceivedStressScale-10assessanalyseRESULTS:withoutliverdiseases824±95±91±14146significantdifferencenon-liverdisease7±3vsp=0842%evenanalysisshowedpatientspositiveeantigen3521926B-related5221869likelyacceptCONCLUSIONS:heavyAcceptancerelatedstatuslevelunderstandingnecessaryprovideeducationreduceincreaseChina:casecomparisonagentspatienthealthcarewoman

Similar Articles

Cited By (2)